Delivery Order SPE2D021D0005-SPE2D322F0876
Award Date
10/26/21
Potential Completion Date
10/29/21
Potential Value
$1.1K
Federal Agency
Medical Supply Chain
Awardee
Genentech Usa, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Genentech USA, Inc. was awarded a $112 firm fixed price delivery order against an unidentified contract vehicle to supply 4554769784 Tamiflu 75 mg capsules in blister packs of 10 to the Defense Logistics Agency Troop Support Medical. Performance will occur in South San Francisco, California by September 17, 2021. No set-aside provisions were applied to this order for pharmaceutical supplies in support of the agency's medical logistics programs. Genentech will serve as the prime contractor to...
This delivery order from the Defense Logistics Agency Troop Support Medical is for four hundred seventy-three dollars to procure Tamiflu 75 mg capsules in blister packs of ten from Genentech USA, Inc. The place of performance is Genentech's facility in South San Francisco, California. The fixed price order is for delivery by August 16, 2022 under a preexisting contract vehicle. No set-aside designation was applied to this award to support DLA Troop Support Medical's stockpiling of antiviral...
The Defense Logistics Agency Troop Support Medical awarded a $172,416.18 Firm Fixed Price delivery order contract to Genentech USA, Inc. for the supply of the antiviral medication oseltamivir phosphate (Tamiflu). The contract, which does not include a set-aside designation, was awarded on September 8, 2017 with a completion date of September 10, 2018. Genentech, a foreign-owned, for-profit biotechnology manufacturer, has provided various pharmaceutical products to U.S. Government agencies...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the supply of oseltamivir phosphate (Tamiflu), an antiviral medication. The $141,052.05 firm-fixed-price delivery order is not associated with any set-aside designation. Genentech holds several established contract vehicles with federal agencies, including a $4.9 billion Federal Supply Schedule with the Department of Veterans Affairs to...
The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Genentech USA, Inc., a biotechnology company that manufactures pharmaceutical products, for the supply of the antiviral medication Oseltamivir Phosphate. The $179,992.80 contract has a completion date of September 23, 2019 and does not utilize any set-asides. Genentech, as the prime contractor, will perform the work at its facility in South San Francisco, California. This delivery order is part of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Genentech USA, Inc., a biotechnology company and manufacturer of pharmaceuticals, for $96,150.00. The award is for the supply of oseltamivir phosphate (commonly known as Tamiflu), an antiviral medication. This delivery order is a part of a larger indefinite delivery contract between Genentech and DLA valued at $27.9 million to fulfill orders for medical supplies and critical pharmaceuticals supporting the Department of...
The Defense Logistics Agency Troop Support Medical awarded a $4,343,441.64 firm fixed price delivery order to Genentech USA, Inc. for the purchase of the antiviral medication oseltamivir phosphate. This order was placed against an existing indefinite delivery contract with the biotechnology manufacturer, which has a history of providing various pharmaceutical products to federal agencies such as the Departments of Health and Human Services, Defense, Justice, and Veterans Affairs. Genentech...
This federal contract award (SPE2DP16D0008|0008) was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Genentech USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, for the delivery of oseltamivir phosphate (the active ingredient in Tamiflu). The $143,455.80 firm fixed-price delivery order contract has a period of performance through September 20, 2017. This award is associated with a larger indefinite delivery contract between Genentech and the...
The Defense Logistics Agency Troop Support Medical awarded a $648,414.70 firm fixed price delivery order to Genentech USA, Inc. of South San Francisco, California. The order is for 8507096058 OTHER MEDICAL products to be delivered between January 15, 2020 and June 23, 2020. As the prime contractor, Genentech will supply unspecified medical products to the DLA Troop Support Medical, the Defense Logistics Agency component that provides worldwide logistics support for medical supplies and equipment...
The Defense Logistics Agency Troop Support Medical awarded a Firm Fixed Price Delivery Order contract to Genentech USA, Inc., a foreign-owned for-profit manufacturer of pharmaceuticals, to provide the antiviral medication Oseltamivir Phosphate. The $150,724.74 contract has a completion date of September 24, 2019 and is not designated as a set-aside. Genentech, which has supplied various drugs to U.S. government agencies through indefinite delivery contracts and Federal Supply Schedules, will...